These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10817504

  • 1. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
    Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R.
    Br J Cancer; 2000 May; 82(10):1682-8. PubMed ID: 10817504
    [Abstract] [Full Text] [Related]

  • 2. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L, Mosberger I, Grusch M, Rudas M, Chott A.
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [Abstract] [Full Text] [Related]

  • 3. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H.
    Cancer Res; 1998 May 15; 58(10):2057-62. PubMed ID: 9605741
    [Abstract] [Full Text] [Related]

  • 5. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S, Nagao M, Kanehiro H, Hisanaga M, Ko S, Ikeda N, Nakajima Y.
    Anticancer Res; 2004 May 15; 24(3a):1569-79. PubMed ID: 15274324
    [Abstract] [Full Text] [Related]

  • 6. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
    Hendricks DT, Taylor R, Reed M, Birrer MJ.
    Cancer Res; 1997 Jun 01; 57(11):2112-5. PubMed ID: 9187105
    [Abstract] [Full Text] [Related]

  • 7. Human lung carcinomas express Fas ligand.
    Niehans GA, Brunner T, Frizelle SP, Liston JC, Salerno CT, Knapp DJ, Green DR, Kratzke RA.
    Cancer Res; 1997 Mar 15; 57(6):1007-12. PubMed ID: 9067260
    [Abstract] [Full Text] [Related]

  • 8. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
    Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Miwa K.
    Int J Oncol; 2001 Jan 15; 18(1):33-9. PubMed ID: 11115536
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling.
    Margalit KA, Cowan RG, Harman RM, Quirk SM.
    Reproduction; 2005 Nov 15; 130(5):751-8. PubMed ID: 16264104
    [Abstract] [Full Text] [Related]

  • 10. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES, Hung MJ, Lu CH, Chiou LC.
    Clin Cancer Res; 2003 Apr 15; 9(4):1393-8. PubMed ID: 12684410
    [Abstract] [Full Text] [Related]

  • 11. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
    Ragnarsson GB, Mikaelsdottir EK, Vidarsson H, Jónasson JG, Olafsdóttir K, Kristjánsdóttir K, Kjartansson J, Ogmundsdóttir HM, Rafnar T.
    Br J Cancer; 2000 Dec 15; 83(12):1715-21. PubMed ID: 11104571
    [Abstract] [Full Text] [Related]

  • 12. FasL:Fas ratio--a prognostic factor in breast carcinomas.
    Reimer T, Herrnring C, Koczan D, Richter D, Gerber B, Kabelitz D, Friese K, Thiesen HJ.
    Cancer Res; 2000 Feb 15; 60(4):822-8. PubMed ID: 10706087
    [Abstract] [Full Text] [Related]

  • 13. Expression of Fas and FasL in human serous ovarian epithelial tumors.
    van Haaften-Day C, Russell P, Davies S, King NJ, Tattersall MH.
    Hum Pathol; 2003 Jan 15; 34(1):74-9. PubMed ID: 12605369
    [Abstract] [Full Text] [Related]

  • 14. Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma.
    Gross N, Balmas K, Beretta Brognara C, Tschopp J.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):111-4. PubMed ID: 11464860
    [Abstract] [Full Text] [Related]

  • 15. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
    Mozzetti S, Ferrandina G, Marone M, D'Ingiullo F, Fruscella E, De Pasqua A, Mancuso S, Scambia G.
    Cancer Detect Prev; 2000 Jan 15; 24(6):536-41. PubMed ID: 11198267
    [Abstract] [Full Text] [Related]

  • 16. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 17. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
    Zhu Q, Liu JY, Yang CM, Xu HW, Zhang AZ, Cui Y, Wang HB, Qin CY, Li YQ.
    Eur J Gastroenterol Hepatol; 2006 Oct 15; 18(10):1071-7. PubMed ID: 16957513
    [Abstract] [Full Text] [Related]

  • 18. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J, Bennett MW, O'Sullivan GC, Roche D, Kelly J, Collins JK, Shanahan F.
    J Pathol; 1998 Nov 15; 186(3):240-6. PubMed ID: 10211111
    [Abstract] [Full Text] [Related]

  • 19. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
    Maas S, Warskulat U, Steinhoff C, Mueller W, Grimm MO, Schulz WA, Seifert HH.
    Urology; 2004 Feb 15; 63(2):392-7. PubMed ID: 14972509
    [Abstract] [Full Text] [Related]

  • 20. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B, Litvak A, Sharma S, Mhashilkar AM, Chada S, Ramesh R.
    Cancer Res; 2005 Apr 15; 65(8):3017-24. PubMed ID: 15833826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.